A hierarchical approach to combine histological grade and immunohistochemical factors to identify high-risk luminal breast cancers

BACKGROUND: The luminal subtype accounts for ~70% of newly diagnosed breast cancer patients. Although it has a better prognosis, approximately 30% of them develop a late relapse. Identifying those patients is of interest to improve treatment decisions. METHODS: A retrospective observational, single-...

Descripción completa

Detalles Bibliográficos
Autores principales: da Luz, Felipe Andrés Cordero, da Costa Marinho, Eduarda, Nascimento, Camila Piqui, de Andrade Marques, Lara, Delfino, Patrícia Ferreira Ribeiro, Antonioli, Rafael Mathias, de Araújo, Rogério Agenor, Silva, Marcelo José Barbosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300407/
https://www.ncbi.nlm.nih.gov/pubmed/35919235
http://dx.doi.org/10.3332/ecancer.2022.1382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300407/
https://www.ncbi.nlm.nih.gov/pubmed/35919235
http://dx.doi.org/10.3332/ecancer.2022.1382

Ejemplares similares